FEops HEARTguide provides additional insights compared to traditional planning for TAVI interventions with Evolut Pro (+) in complex anatomies
FEops HEARTguide changed the preprocedural planning in 35% of the patients, well predicted the risk for PVL and identified the risk for new PPI post‐TAVI.*
Pr. Nicolas M. Van Mieghem - PCR London Valves 2022.
FEops HEARTguide helps physicians to accurately predict which patients are at risk for new pacemakers or paravalvular leaks. Procedure simulations complement contemporary precision medicine.
* PRECISE‐TAVI trial, Clinical value of CT‐derived simulations of transcatheter‐aortic‐valve‐implantation in challenging anatomies. DOI: 10.1002/ccd.30816
The trial data is clear.
When will you start using FEops HEARTguide for your patients?